New Botox-Like shot may give voice disorder patients months of relief

NCT ID NCT05158166

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new type of botulinum toxin injection (DAXI) for people with adductor spasmodic dysphonia, a condition that causes the voice to spasm and sound strained. 22 adults who had previously been helped by standard Botox injections received a single DAXI injection into their voice box muscles. The goal was to see if DAXI could provide longer-lasting voice improvement, potentially reducing the need for repeat injections every few months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDUCTOR SPASMODIC DYSPHONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCSF

    San Francisco, California, 94118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.